Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Journal of Cancer

• Publication date

  2012-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.26405PMID 22052531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening

  2012cited by this paper
• Circulating miRNAs are correlated with tumor progression in prostate cancer

  2011cited by this paper
• Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients.

  2011cited by this paper
• Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage

  2011cited by this paper
• Androgen regulation of micro‐RNAs in prostate cancer

  2011cited by this paper
• Pre-processing and differential expression analysis of Agilent microRNA arrays using the AgiMicroRna Bioconductor library

  2011cited by this paper
• A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis.

  2011cited by this paper
• Serum miRNA‐21: Elevated levels in patients with metastatic hormone‐refractory prostate cancer and potential predictive factor for the efficacy of docetaxel‐based chemotherapy

  2011cited by this paper
• Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

  2010cited by this paper
• New developments in the medical management of prostate cancer.

  2010cited by this paper
• Roles of small RNAs in tumor formation.

  2010cited by this paper
• Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases

  2010cited by this paper
• Integrative genomic profiling of human prostate cancer.

  2010cited by this paper
• Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression.

  2009cited by this paper
• MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse β-Amyloid Precursor Protein-converting Enzyme 1*

  2009cited by this paper
• Targeting TGF-β in prostate cancer: therapeutic possibilities during tumor progression

  2009cited by this paper
• Interspecies comparison of prostate cancer gene‐expression profiles reveals genes associated with aggressive tumors

  2009cited by this paper
• Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray

  2009cited by this paper
• Alternative splicing and biological heterogeneity in prostate cancer

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• miRecords: an integrated resource for microRNA–target interactions

  2008cited by this paper
• Most mammalian mRNAs are conserved targets of microRNAs.

  2008cited by this paper
• Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.

  2008cited by this paper
• Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

  2008cited by this paper
• miRNAminer: A tool for homologous microRNA gene search

  2008cited by this paper
• Serum markers for prostate cancer: a rational approach to the literature.

  2008cited by this paper
• Wnt signaling and prostate cancer.

  2008cited by this paper
• The emergent role of microRNAs in molecular diagnostics of cancer.

  2008cited by this paper
• Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.

  2008cited by this paper
• A Mouse to Human Search for Plasma Proteome Changes Associated with Pancreatic Tumor Development

  2008cited by this paper
• Human multipotent stromal cells from bone marrow and microRNA: Regulation of differentiation and leukemia inhibitory factor expression

  2008cited by this paper
• Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• Discovery of cancer biomarkers through the use of mouse models.

  2007cited by this paper
• Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals

  2007cited by this paper
• GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists

  2007cited by this paper
• Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples.

  2007cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• Estimates of the cancer incidence and mortality in Europe in 2006.

  2006cited by this paper
• MicroRNA expression profiles classify human cancers

  2005cited by this paper
• A pancreatic islet-specific microRNA regulates insulin secretion

  2004cited by this paper
• Androgen-independent prostate cancer: potential role of androgen and ErbB receptor signal transduction crosstalk.

  2003cited by this paper
• Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease.

  2001cited by this paper
• Pathologic progression of autochthonous prostate cancer in the TRAMP model

  1999cited by this paper
• Metastatic prostate cancer in a transgenic mouse.

  1996cited by this paper
• Cancer statistics

  1989cited by this paper
• Cáncer

  1939cited by this paper
• Systematic analysis of

  year unknowncited by this paper

• Nanoformulation-assisted early diagnosis of prostate cancer: Advances and perspectives

  2025cites this paper
• Research of the unrecognised functions of miR-375 in prostate cancer cells.

  2024cites this paper
• Except for Robust Outliers, Rapamycin Increases Lesion Burden in a Murine Model of Cerebral Cavernous Malformations

  2024cites this paper
• Recent progress in microRNA research for prostate cancer

  2024cites this paper
• MicroRNA profile of extracellular vesicles released by Müller glial cells

  2024cites this paper
• Research Progress of Serum miRNA-135, miRNA-141 and PSA in the Diagnosis and Prognosis of Prostate Cancer

  2024cites this paper
• Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway

  2024cites this paper
• Prostate‐derived circulating microRNAs add prognostic value to prostate cancer risk calculators

  2023cites this paper
• Differential Expression of miRNAs Contributes to Tumor Aggressiveness and Racial Disparity in African American Men with Prostate Cancer

  2023cites this paper
• Prostate-derived circulating microRNAs add prognostic value to prostate cancer risk calculators

  2023cites this paper
• The Emerging Role of Exosomal miRNAs as Biomarkers for Early Cancer Detection: A Comprehensive Literature Review

  2023cites this paper
• Nanoribbon Biosensor-Based Detection of microRNA Markers of Prostate Cancer

  2023influential citation
• Emerging role of miRNA in prostate cancer: A future era of diagnostic and therapeutics.

  2023cites this paper
• Screening and validation of novel serum panel of microRNA in stratification of prostate cancer

  2023cites this paper
• Orchestration of miRNA patterns by testosterone and dietary tomato carotenoids during early prostate carcinogenesis in TRAMP mice.

  2023cites this paper
• miR-375 Induced the Formation and Transgenerational Inheritance of Fatty Liver in Poultry by Targeting MAP3K1

  2022cites this paper
• The role of miR-200 family in the regulation of hallmarks of cancer

  2022cites this paper
• Dietary stilbenes as modulators of specific miRNAs in prostate cancer

  2022cites this paper
• MiRNA biomarkers in cancers of the male reproductive system: Are we approaching clinical application?

  2022cites this paper
• Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer

  2022cites this paper
• The Potential Diagnostic and Prognostic Value of Circulating MicroRNAs in the Assessment of Patients With Prostate Cancer: Rational and Progress

  2022cites this paper
• Signaling Pathways and Targeted Therapies for Stem Cells in Prostate Cancer.

  2022cites this paper
• Diagnostic Value of microRNA-375 as Future Biomarker for Prostate Cancer Detection: A Meta-Analysis

  2022cites this paper
• Advances in studies of circulating microRNAs: origination, transportation, and distal target regulation

  2022cites this paper
• Urinary microRNAs can predict response to abiraterone acetate in castration resistant prostate cancer: A pilot study

  2021cites this paper
• MicroRNA and circRNA Expression Analysis in a Zbtb1 Gene Knockout Monoclonal EL4 Cell Line

  2021cites this paper
• Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients

  2021cites this paper
• Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters

  2021cites this paper
• Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer

  2021cites this paper
• CMAR_A_272140 25..35

  2021cites this paper
• Nanoribbon Biosensor in the Detection of miRNAs Associated with Colorectal Cancer

  2021cites this paper
• Grape Powder Supplementation Attenuates Prostate Neoplasia Associated with Pten Haploinsufficiency in Mice Fed High-Fat Diet.

  2020cites this paper
• Coordinated AR and microRNA regulation in prostate cancer

  2020cites this paper
• microRNA-141-3p-containing small extracellular vesicles derived from epithelial ovarian cancer cells promote endothelial cell angiogenesis through activating the JAK/STAT3 and NF-κB signaling pathways

  2020cites this paper
• MiR-93/miR-375: Diagnostic Potential, Aggressiveness Correlation and Common Target Genes in Prostate Cancer

  2020cites this paper
• Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia

  2020cites this paper
• MiRNA-Based Inspired Approach in Diagnosis of Prostate Cancer

  2020cites this paper
• Circulating microRNAs and liquid biopsy: murine xenograft models for technical validation of clinical protocols

  2019influential citation
• HIF1α promotes prostate cancer progression by increasing ATG5 expression

  2019cites this paper
• The Potential Prognostic and Diagnostic Role of MiRNAs as Novel Biomarkers for Prostate Cancer

  2019cites this paper
• Increased Soluble CMG2 Serum Protein Concentration Is Associated with the Progression of Prostate Carcinoma

  2019cites this paper
• Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in prostate cancer: Current status and future perspectives

  2019cites this paper
• Digitoxin Inhibits Epithelial-to-Mesenchymal-Transition in Hereditary Castration Resistant Prostate Cancer

  2019influential citation
• Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction

  2019cites this paper
• Interplay between the androgen receptor signalling axis and microRNAs in prostate cancer.

  2019cites this paper
• Novel Biomarkers for Prostate Cancer Detection and Prognosis.

  2018cites this paper
• Increased level of miRNA 30b-3p in patients with prostatic hyperplasia and testosterone with high-level of prostate-specific antigen

  2018cites this paper
• Universal, colorimetric microRNA detection strategy based on target-catalyzed toehold-mediated strand displacement reaction

  2018cites this paper
• Enhanced expression of miR-375 increases chemotherapy sensitivity of prostate cancer to cisplatin

  2018cites this paper
• Role of exosomal small RNA in prostate cancer metastasis

  2018cites this paper
• microRNA-141 as a diagnostic and prognostic biomarker for prostate cancer in Egyptian population: Pilot study

  2018cites this paper
• Increased levels of serum miR‐148a‐3p are associated with prostate cancer

  2018cites this paper
• Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)

  2018cites this paper
• MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/β-catenin signaling.

  2018cites this paper
• The microRNA signatures: aberrantly expressed miRNAs in prostate cancer

  2018cites this paper
• Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA)

  2018cites this paper
• A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer

  2018cites this paper
• Functional roles and potential clinical application of miRNA‐345‐5p in prostate cancer

  2018cites this paper
• A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer

  2018cites this paper
• Emerging microRNAs in cancer diagnosis, progression, and immune surveillance.

  2018cites this paper
• The effects of miR-375 expression in NSCLC via the 14-3-3ζ/ERK/MYC pathway

  2018cites this paper
• Prostate Carcinomas in African Americans Have Distinct miRNA Expression and Biological Markers for Poor Prognosis

  2018cites this paper
• Ultrasensitive DNA detection based on target-triggered rolling circle amplification and fluorescent poly(thymine)-templated copper nanoparticles

  2018cites this paper
• Diagnostic performance of microRNAs in the circulation in differential diagnosis of BPH, chronic prostatitis and prostate cancer

  2018cites this paper
• Resveratrol and pterostilbene as a microRNA‐mediated chemopreventive and therapeutic strategy in prostate cancer

  2017cites this paper
• Circulating miRNAs as novel diagnostic biomarkers in hepatocellular carcinoma detection: a meta-analysis based on 24 articles

  2017cites this paper
• Circulating MicroRNAs as Markers of Prostate Cancer Progression: a Time-based Approach

  2017influential citation
• MTA1‐activated Epi‐microRNA‐22 regulates E‐cadherin and prostate cancer invasiveness

  2017cites this paper
• miRNAs as novel biomarkers in the management of prostate cancer

  2017cites this paper
• Deregulation of MiR-34 b / Sox 2 Predicts Prostate Cancer Progression

  2017cites this paper
• Extracellular vesicles as a source for non‐invasive biomarkers in bladder cancer progression

  2017cites this paper
• Exosomal and Non‐Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis

  2017cites this paper
• Prostate Cancer Biomarkers in Circulation

  2017cites this paper
• MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes

  2017cites this paper
• Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer

  2017cites this paper
• Engineering innovative solutions to screen for prostate cancer

  2017cites this paper
• Discovery of Novel Diagnostic Biomarkers on Prostate Tumor Microparticles for Discriminating Between Low and High Risk Prostate Cancer and Improving Prostate Cancer Screening

  2017cites this paper
• miR-141-3p Suppresses Expression of Androgen Receptors and Functions as a Tumor Suppressor Gene in Prostate Carcinogenesis

  2017cites this paper
• MicroRNAs in prostate cancer: Functional role as biomarkers.

  2017cites this paper
• MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2.

  2017cites this paper
• The Role of Noncoding RNAs in Prostate Cancer

  2017cites this paper
• A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer

  2017cites this paper
• miRNAs associated with prostate cancer risk and progression

  2017influential citation
• Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.

  2017cites this paper
• Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?

  2016cites this paper
• MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular Atrophy

  2016cites this paper
• A microRNA/Runx1/Runx2 network regulates prostate tumor progression from onset to adenocarcinoma in TRAMP mice

  2016cites this paper
• MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity

  2016cites this paper
• Oxidative stress in prostate hyperplasia and carcinogenesis

  2016cites this paper
• Prostasomes as a source of diagnostic biomarkers for prostate cancer.

  2016cites this paper
• Circulating microRNA signature for the diagnosis of very high-risk prostate cancer

  2016cites this paper
• MicroRNA Theranostics in Prostate Cancer Precision Medicine.

  2016cites this paper
• MicroRNA-298 inhibits malignant phenotypes of epithelial ovarian cancer by regulating the expression of EZH2

  2016cites this paper
• Hsa-miR-375 is a predictor of local control in early stage breast cancer

  2016cites this paper
• MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer

  2016cites this paper
• The utility of urine-circulating miRNAs for detection of prostate cancer

  2016cites this paper
• The translational potential of microRNAs as biofluid markers of urological tumours

  2016cites this paper
• Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer.

  2016cites this paper
• Reproducible and Reliable Real-time PCR Assay to Measure Mature Form of miR-141

  2016cites this paper
• Lectin‐induced agglutination method of urinary exosomes isolation followed by mi‐RNA analysis: Application for prostate cancer diagnostic

  2016influential citation